Royal Bank of Canada’s Metacrine, Inc. Common Stock MTCR Stock Holding History
Bought
Maintained
Sold
Other funds holding MTCR
BCM
JC
AG
WS
Royal Bank of Canada's MTCR Position: Q1 2023 in Review
Royal Bank of Canada sold out of Metacrine, Inc. Common Stock (MTCR) in Q1 2023, closing a stake of 5 shares.
Royal Bank of Canada first reported a position in MTCR in Q4 2020 and held it in 9 quarters. The position peaked at $298K in Q1 2021. 5 funds tracked by Wall St. Rank hold MTCR as of Q1 2023.
- Royal Bank of Canada reported no remaining Metacrine, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
- Royal Bank of Canada sold 5 Metacrine, Inc. Common Stock shares in Q1 2023.
- Royal Bank of Canada first reported a position in Metacrine, Inc. Common Stock in Q4 2020 and held it in 9 quarters.
- Royal Bank of Canada's Metacrine, Inc. Common Stock position peaked at $298K in Q1 2021.
- 5 funds tracked by Wall St. Rank held Metacrine, Inc. Common Stock as of Q1 2023.
Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.